Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Number of holders
-
36
-
Total 13F principal, excl. options
-
300,962,722
-
Principal change
-
-10,697,000
-
Total reported value, excl. options
-
$403,720,012
-
Value change
-
+$10,712,324
-
Number of buys
-
12
-
Number of sells
-
-26
-
Price
-
$1.32
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q2 2020
49 filings reported holding 09061GAF8 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q2 2020.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 has 36 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $300,962,722 of principal
.
Largest 10 bondholders include Weiss Asset Management LP ($58,471,000 of principal), D. E. Shaw & Co., Inc. ($49,485,000 of principal), Invesco Ltd. ($32,836,000 of principal), FRANKLIN RESOURCES INC ($29,700,000 of principal), BANK OF AMERICA CORP /DE/ ($23,671,000 of principal), Polar Capital LLP ($18,000,000 of principal), Sculptor Capital LP ($12,000,000 of principal), CALAMOS ADVISORS LLC ($9,964,000 of principal), STATE STREET CORP ($9,800,000 of principal), and CSS LLC/IL ($9,500,000 of principal).
This table shows the top 36 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.